CTDI vol ( mGy ) |
4.00 |
35.20 |
14.58 |
8.68 |
DLP ( mGy . cm ) |
215.0 |
1606.80 |
735.23 |
352.63 |
Effective dose ( mSv ) |
3.80 |
28.44 |
13.01 |
6.24 |
CTDI vol ( mGy ) |
5.48 |
15.83 |
9.64 |
3.29 |
DLP ( mGy . cm ) |
205.35 |
643.10 |
367.15 |
137.60 |
Effective dose ( mSv ) |
3.63 |
11.38 |
6.49 |
2.43 |
CTDI vol ( mGy ) |
7.08 |
12.27 |
9.14 |
1.69 |
DLP ( mGy . cm ) |
244.74 |
686.21 |
380.05 |
133.40 |
Effective dose ( mSv ) |
4.33 |
12.14 |
6.72 |
2.36 |
CTDI vol ( mGy ) |
4.55 |
10.63 |
6.53 |
2.17 |
DLP ( mGy . cm ) |
133.80 |
403.70 |
250.94 |
82.87 |
Effective dose ( mSv ) |
2.36 |
7.14 |
4.44 |
1.46 |
Radiotherapy planning CT-scans |
Diagnostic CT-scans |
||
Pulmonary embolism |
Infectious lung disease |
COPD |
|
715 ( 209 – 1564 ) |
357 ( 199 – 626 ) |
369 ( 238 – 668 ) |
244 ( 130 – 393 ) |
Table 7 . Correlation coefficients ( p-values ) for gender of patients , clinical indication , age , BMI and the effective dose . | |||
Effective dose ( p-value ) | |||
Radiotherapy planning CT |
Diagnostic CT |
||
Gender
Clinical indication
|
Student ’ s t-test |
0.076 |
0.111
0.001
|
Age
BMI
|
Spearman correlation |
0.216
0.000
|
0.036
0.231
|
** Correlation is significant at the 0.05 level ( two-tailed ). |